Kansas Health Science Center Adds Angela Carrick, DO, Eva Shay, DO, and Terence Ma, Ph.D., to Faculty

The proposed Kansas Health Science Center – Kansas College of Osteopathic Medicine (KHSC-KansasCOM), currently under construction in downtown Wichita,…

Cardiac Electrophysiology Lab Clinicians Gain New Resource with Launch of Medline ReNewal Continuing Education Series

 Medline ReNewal today announced the launch of a continuing education (CE) course series to help cardiac electrophysiology…

New AARP Analysis Shows Nursing Home Vaccination Rates in Ohio Still Fall Short of Benchmark

Cases of COVID decreased only slightly among Ohio nursing home residents and staff over the four weeks ending July…

Prospect Medical Holdings Announces Partnership with Global Care Medical Group IPA

Prospect Medical Holdings (PMH) has announced an alliance with Global Care Medical Group, Inc. (GCMG) to…

Leading Diabetes Advocacy Groups Urge CDC to Include Americans with Diabetes in Those Prioritized for COVID-19 Vaccine Boosters

 Today, the American Diabetes Association® and 14 other leading voluntary health organizations and medical societies concerned with…

Vivex Biologics, Inc. Launches CYGNUS® Matrix Disks

Vivex Biologics, Inc., a leading regenerative medicine company specializing in the development of naturally sourced treatments,…

Announcing Awards Of Community Heart & Soul® Seed Grants

Community Heart & Soul is pleased to award its first three $10,000 Seed Grants to Akron and Westfield, Iowa; Cambridge, Illinois; and Winchendon,…

Nektar Therapeutics Reports Second Quarter 2021 Financial Results

Nektar Therapeutics (Nasdaq: NKTR) today reported financial results for the second quarter ended June 30, 2021. Cash and investments…

Bausch Health Announces Plans To Pursue An Initial Public Offering Of Solta Medical

Transaction Will Enable Bausch Health to Continue to Execute on its Previously Announced Spinoff of its…

Tenaya Therapeutics Announces Closing of Upsized Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Share

Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a biotechnology company with a mission to discover, develop and deliver…